Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction: The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.

Autor: Jones-Tabah J; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., He K; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Karpilovsky N; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Senkevich K; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., Deyab G; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Pietrantonio I; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Goiran T; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Cousineau Y; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., Nikanorova D; Research Department, Bioinformatics Institute, Saint-Petersburg, Russia., Goldsmith T; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., Del Cid Pellitero E; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Chen CX; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., Luo W; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., You Z; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., Abdian N; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., Ahmad J; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., Ruskey JA; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., Asayesh F; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Human Genetics, McGill University, Montréal, Canada., Spiegelman D; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Fahn S; Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA., Waters C; Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA., Monchi O; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.; Département de Radiologie, Radio-Oncologie Et Médecine Nucléaire, Université de Montréal, Montréal, QC, Canada.; Centre de Recherche de L'Institut Universitaire de Gériatrie de Montréal, Montréal, QC, Canada., Dauvilliers Y; Sleep Unit, Department of Neurology, National Reference Center for Narcolepsy, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, Montpellier, France., Dupré N; Neuroscience Axis, CHU de Québec - Université Laval, Quebec City, G1V 4G2, Canada.; Department of Medicine, Faculty of Medicine, Université Laval, Québec, QC, G1V 0A6, Canada., Miliukhina I; Institute of the Human Brain of RAS, St. Petersburg, Russia., Timofeeva A; First Pavlov State Medical, University of St. Petersburg, Saint-Petersburg, Russia., Emelyanov A; First Pavlov State Medical, University of St. Petersburg, Saint-Petersburg, Russia., Pchelina S; First Pavlov State Medical, University of St. Petersburg, Saint-Petersburg, Russia., Greenbaum L; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Hassin-Baer S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.; Department of Neurology, The Movement Disorders Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel., Alcalay RN; Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA.; Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Milnerwood A; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., Durcan TM; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., Gan-Or Z; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Human Genetics, McGill University, Montréal, Canada., Fon EA; Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, McGill Parkinson Program, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada. ted.fon@mcgill.ca.; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada. ted.fon@mcgill.ca.

Publikováno v: Molecular neurodegeneration [Mol Neurodegener] 2024 Dec 18; Vol. 19 (1), pp. 94. Date of Electronic Publication: 2024 Dec 18.

The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.

Autor: Jones-Tabah J; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., He K; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Senkevich K; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., Karpilovsky N; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Deyab G; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Cousineau Y; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., Nikanorova D; Research Department, Bioinformatics Institute, Saint-Petersburg, Russia., Goldsmith T; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., Del Cid Pellitero E; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Chen CX; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., Luo W; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., You Z; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., Abdian N; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., Pietrantonio I; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Goiran T; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Ahmad J; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., Ruskey JA; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., Asayesh F; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Human Genetics, McGill University, Montréal, Canada., Spiegelman D; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada., Waters C; Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, NY, USA., Monchi O; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.; Département de radiologie, radio-oncologie et médecine nucléaire, Université de Montréal, Montréal, QC, Canada.; Centre de recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, QC, Canada., Dauvilliers Y; National Reference Center for Narcolepsy, Sleep Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, Montpellier, France., Dupré N; Neuroscience Axis, CHU de Québec - Université Laval, Quebec City, G1V 4G2, Canada.; Department of Medicine, Faculty of Medicine, Université Laval, Québec, QC, G1V 0A6, Canada., Miliukhina I; Institute of the Human Brain of RAS, St. Petersburg, Russia., Timofeeva A; First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia., Emelyanov A; First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia., Pchelina S; First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia., Greenbaum L; Institute of the Human Brain of RAS, St. Petersburg, Russia.; First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Hassin-Baer S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.; The Movement Disorders Institute, Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel., Alcalay RN; Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, NY, USA.; Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Milnerwood A; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada., Durcan TM; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada., Gan-Or Z; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Human Genetics, McGill University, Montréal, Canada., Fon EA; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Nov 15. Date of Electronic Publication: 2023 Nov 15.